Amgen Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Amgen Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue36.7533.4228.1926.3225.9825.4223.3623.75
Cost of Revenue6.4212.868.456.416.456.164.364.10
Gross Profit30.3320.5719.7419.9219.5319.2719.0119.65
Operating Expenses
Research & Development7.275.964.784.436.324.214.123.74
Selling, General & Administrative7.057.106.185.925.565.925.225.33
Operating Expenses15.4413.3111.8410.3511.8910.139.339.38
Operating Income14.897.267.909.577.649.149.6710.26
Other Income/Expense
Interest Income0.000.001.200.130.010.000.000.67
Interest Expense2.763.162.88-1.531.20-1.000.001.39
Other Income/Expense-5.92-2.652.83-0.81-0.26-0.26-0.750.00
Income
Income Before Tax8.984.617.867.356.708.139.149.55
Income Tax Expense1.270.521.140.790.810.871.301.15
Net Income7.714.096.726.555.897.267.848.39
Net Income - Continuous Operations7.714.096.726.555.890.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA17.1313.3614.8012.1711.3013.0012.6312.88
EBIT11.9010.0910.738.757.909.4010.4310.94
Depreciation & Amortization5.385.594.070.660.640.640.640.00
Earnings Per Share
Basic EPS14.008.0013.0012.0010.0012.0013.0013.00
Diluted EPS14.008.0012.0012.0010.0012.0013.0013.00
Basic Shares Outstanding0.540.540.540.540.570.590.610.66
Diluted Shares Outstanding0.540.540.540.540.570.590.610.67